Eurogin is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Dear friends and colleagues,
Since its creation three decades ago, the EUROGIN congress has gained a strong reputation as one of the leading international conferences on HPV infection and associated cancers. The meeting offers a forum for high-level scientific exchange involving multiple disciplines, with the aim to translate research into clinical practice. Thanks to the top-ranking program committee the congress program offers up-to-date scientific information on the full range of HPV-related diseases.
For non-vaccinated populations, early detection and HPV based screening remains to be the key challenge.
The perspective of eliminating HPV infection and related cancers continues to be a major goal. HPV immunization on a large scale opens a priceless opportunity to reduce the burden of cervical, ano-genital and oral cancer all over the world. The journey started some time ago, but the destination has now come into sight: elimination of HPV related cancer.
As usual, the EUROGIN congress will offer a variety of educational opportunities for attendees: training courses, specialized workshops, scientific sessions, clinical sessions, free communications and poster presentations.
On behalf of the EUROGIN Organizing Committee, I am pleased to welcome you to EUROGIN.
Chairman of the Scientific Committee
We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy and Cookie Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.